Indeed, CAR-T cells incorporating nanobodies specific to anti-EIIIB fibronectin exhibited enhanced tumor infiltration, induction of necrosis, and reduced stromal ECM and neovasculature in mouse models, leading to delayed tumor growth (35). Here, FN1 is linked to neoplasm.